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ABSTRACT
Objective: compare chronic hepatitis B patients to those superinfected with hepatitis D virus, according to Child-Pugh score regarding 
disease severity. Method: retrospective descriptive study, performed with 59 patients followed in the ambulatory, of which 22 (37.3%) 
were chronically infected with hepatitis B virus (Group HBV) and 37 (62.7%) superinfected with Delta virus (Group HBV+HDV); 
variables of sex, age and items of Child-Pugh score were collected by consulting medical records. Results: out of the patients, 57.6% 
were male, with a mean age of 30.5 years. Score A, which indicates lesser severity, was found in 100% of group HBV and 78.4% of 
group HBV+HDV. Score B, which indicates greater severity, was found only in group HBV+HDV in 21.6% of the patients. Conclusion: 
by means of the Child-Pugh score, it was observed that patients with superinfection by HDV tended to present a worse prognosis.
Descriptors: Hepatitis B; Hepatitis D; Prognosis; Gastroenterology; Infectology.
RESUMO
Objetivo: comparar os pacientes com hepatite B crônica com superinfectados pelo vírus D segundo escore de Child-Pugh quanto 
à gravidade da doença. Método: estudo descritivo retrospectivo, realizado com 59 pacientes acompanhados em ambulatório, 
sendo 22 (37,3%) cronicamente infectados pelo vírus da hepatite B (Grupo VHB) e 37 (62,7%) com superinfecção por vírus 
Delta (Grupo VHB+VHD); foram coletadas variáveis quanto ao sexo, idade e referentes ao escore de Child-Pugh por meio de 
consulta a prontuários. Resultados: entre os pacientes 57,6% era do sexo masculino, com idade média de 30,5 anos. O escore 
A, que indica menor gravidade, foi encontrado em 100% do grupo VHB e 78,4% do grupo VHB+VHD. O escore B, que indica 
maior gravidade, foi encontrado apenas no grupo VHB+VHD em 21,6% dos pacientes. Conclusão: por meio do escore de 
Child-Pugh, observou-se que os pacientes com superinfecção por VHD tendem a apresentar pior prognóstico.
Descritores: Hepatite B; Hepatite D; Prognóstico; Gastroenterologia; Infectologia.
RESUMEN
Objetivo: comparar los pacientes con hepatitis B crónica con superinfectados por el virus D según escore de Child-Pugh 
cuanto a la gravedad de la enfermedad. Método: estudio descriptivo retrospectivo, realizado con 59 pacientes acompañados en 
ambulatorio, siendo 22 (37,3%) crónicamente infectados por el virus de hepatitis B (Grupo VHB) y 37 (62,7%) con superinfección 
por virus Delta (Grupo VHB+VHD); fueron colectadas variables cuanto al sexo, edad y referentes al escore de Child-Pugh por 
medio de consulta a prontuarios. Resultados: entre los pacientes 57,6% era de varones, con edad media de 30,5 años. El escore 
A, que indica menor gravedad, fue encontrado en 100% del grupo VHB y 78,4% del grupo VHB+VHD. El escore B, que indica 
mayor gravedad, fue encontrado apenas en el grupo VHB+VHD en 21,6% de los pacientes. Conclusión: por medio del escore 
de Child-Pugh, se observó que los pacientes con superinfección por VHD tienden a presentar peor pronóstico.
Descriptores: Hepatitis B; Hepatitis D; Pronóstico; Gastroenterología; Infección.
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INTRODUCTION
Chronic hepatitis due to B virus (HBV) and those associated 
with D virus (HDV) constitute a severe public health problem 
throughout the world, since it is a chronic condition resulting 
in constant demands on the health services, as well as consid-
erable loss in the quality of life among infected patients, faced 
with the characteristics of morbidity and mortality related to these 
infections(1–3).
Both viruses are transmitted parenterally and capable of 
leading to the development of chronic hepatic disease with 
many evolutionary complications, such as pictures of polyar-
thritis, glomerulonephritis, rheumatic polymyalgia, cryoglob-
ulinemia, among others and especially for hepatic cirrhosis 
and hepatocellular carcinoma (HCC)(4).
This type of infection presents a global distribution, where 
studies have suggested that HBV has a contamination poten-
tial that could affect approximately one third of the total world 
population. It has been estimated that there are in the region 
of 300 to 400 million chronic carriers, of which 15 to 20 mil-
lion could present concomitant infection by HDV(2,5–7).
In Brazil, a national study revealed differences in the epide-
miological patterns between regions, as well as estimating that 
15% of the population has already come into contact with HBV, 
a condition necessary for infection by HDV and that chronic 
hepatitis B already affects approximately 1% of the population(8).
It is important to report that infection by HDV is considered 
a co-infection when it occurs in the primary (acute) phase of 
HBV and to be a superinfection when occurring in chronic 
hepatitis B carriers(4,9).
HDV has a world distribution with varying prevalence 
rates. In Central Europe the disease affects 47.6% of AgHBs 
positive patients in Romania and 13.9% in Hungary. In Africa, 
the infection principally affects the occidental and central 
countries, varying from 1.3% in Nigeria up to 66% in Gabon. 
In Egypt infection by HDV is an estimated 20%. In Asia, the 
prevalence could reach 66.7% in Taiwan, while in Mongolia 
82% of HBV infected patients presenting advanced hepatic 
disease are superinfected with HDV(10). 
In South America, HDV superinfection is predominant in 
the Amazon Basin, notably in the Brazilian Western Amazon, 
where anti-HDV seropositivity could reach up to 85% of the 
AgHBs positive patients(2,10-11).
Early evolution into the more severe complications of he-
patic disease has been systematically related to HDV superinfec-
tion(7,12-13). This represents a serious health problem in the context 
of the Brazilian Occidental Amazon, principally due to the rela-
tionship between the infection and exacerbation of symptoms(14).
Complications arising from chronic HBV infection repre-
sent one of the most common indications for kidney trans-
plantation over the previous 10 years, while approximately 
25% of chronic HBV carriers can develop cirrhosis or HCC. 
Superinfection with HDV, a known risk factor for terminal 
hepatic disease, also has limited treatment options with liver 
transplantation remaining the only option(15).
In Brazil 2006, the Ministry of Health published Decree nº 
1.160, after which the MELD-PELD (Model for End-stage Liver 
Disease – Pediatric End-stage Liver Disease) score became used 
to estimate the prognosis recommended for indication of hepat-
ic transplantation in the Sistema Único de Saúde [Single Health 
System]. Later, Decree MS nº 1.160/2006 was revoked by De-
cree no. 2.600, dated 21 October 2009, also from the Health 
Ministry, which reformulated the technical regulations of the na-
tional transplantation system and maintained the recommenda-
tion to use the MELD-PELD score for this purpose(16-17).
Despite the specific indication, Brazilian legislation does not 
impede the use of other mechanisms for the prognostic estimator. 
In this sense, the Secretary of Health Surveillance and the Depart-
ment of STDs, HIV and viral hepatitis of the Ministry of Health 
have recommended, since 2010, via the Clinical and Therapeutic 
Guidelines for the Treatment of Chronic Hepatitis B Virus and 
co-infections, the use of the Child-Pugh score as a prognostic esti-
mator, inclusively when considering the indication for liver trans-
plantation(18). The Child-Pugh score is considered to be a simple 
and easily adapted instrument, that is capable of estimating the 
health conditions of patients with cirrhosis and HCC(19-20). 
Thus, considering the elevated endemic pattern of HBV 
infection and HDV superinfection in the Brazilian Western 
Amazon, as well as the exacerbation of signs and symptoms 
and early evolution to final stages of HDV-related chronic 
hepatitis(12,21), in addition to the scarcity of scientific studies 
realized in the Brazilian Western Amazon on this subject(14,22), 
the present study aimed to compare patients with chronic 
hepatitis B and those superinfected with D-virus according to 
the Child-Pugh score for disease severity.
METHOD
Ethical aspects 
The research was approved by the Research Ethics Commit-
tee of the Universidade Federal de São Paulo – Unifesp on 21 
December, 2012.
Design, study location and period
A retrospective descriptive study was performed from June 
to December 2014, at the Sanitary Dermatology Hospital in 
the city of Cruzeiro do Sul - Acre, Brazilian Western Amazon, 
which is a regional reference center for the treatment of patients 
diagnosed with chronic hepatitis due to HBV and superinfection 
with HDV; 522 patients were registered in the service.
Population or sample; inclusion and exclusion criteria
The study population comprised all patients diagnosed with 
chronic hepatitis B and those superinfected with HDV, whose 
clinical and laboratory follow-up began in 2007 and continued 
until 2012, amounting to a total of 134. Patients were excluded 
that presented a diagnosis of HIV, hepatitis C infection, malignant 
neoplasia unrelated to infectious liver disease, autoimmune dis-
ease, chronic decompensated conditions, and patients who had 
not performed all laboratory tests necessary to calculate the Child-
Pugh score. After applying the above mentioned criteria, 38 pa-
tients with chronic hepatitis B diagnosis and 37 superinfected with 
HDV were excluded because they presented one or more of the 
exclusion criteria. A total of 59 patients were included in the study.
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Study protocol and data collection
The 59 patients selected to participate in the study were di-
vided into two groups: patients chronically infected with virus B 
(Group HBV), comprising 22 individuals; and patients superin-
fected with HDV (Group HBV+HDV), formed by 37 patients.
Data collection was realized by consultation of medical 
records; the collection instrument used included the follow-
ing variables: sex, age, serum bilirubin, serum albumin, pro-
thrombin time (INR), and records of clinical conditions such 
as ascites and neurological disorders related to chronic liver 
disease due to HBV and HDV.
The following clinical and laboratory data were used to cal-
culate the Child-Pugh score: serum bilirubin and albumin, pres-
ence or absence of ascites, presence or absence of neurological 
disorder, and prothrombin time. The score values range from 
5 to 15 points, as shown in Chart 1, and are classified from A 
to C (Score A, 5 to 6 points, B,7 to 9 and C, 10 to 15). Patients 
with Score B, i.e. ≥ 7, present a poor prognosis and should be 
evaluated regarding their indication for liver transplantation(18,23).
As for age, patients in the HBV group presented a mean of 
30 years, similar to the mean age of the HBV + HDV group, 
which was 31. The mean for the total population was 30.5 
years.
Regarding the Child-Pugh score, for both groups classifica-
tion A (5-6) presented a higher frequency, representing 100% 
of those belonging to the HBV group and 78.4% of those who 
composed the HBV + HDV group. Only in the HBV + HDV 
group, results with a B score (7-9) were obtained, correspond-
ing to 21.6% of the individuals in the group. None of the pa-
tients had scores equivalent to classification C (10-9). There was 
no significant difference between the groups when compared 
to the scores, regardless of the classification (see Table 1).
Chart 1 – Child-Pugh score(18,23)
Cirrhosis – Child-
Pugh classification 
factor
1 point 2 points 3 points
Serum bilirubin 
μmol/l (mg/dl)
< 34 
(<2.0)
34-51  
(2.0-3.0)
> 51  
(> 3.0)
Serum albumin 
g/l (g/dl)
> 35  
(> 3.5)
30-35  
(3.0-3.5)
< 30  
(< 3.0)
Ascites None Easily controlled
Poorly 
controlled
Neurological 
alterations None Minimum
Advanced 
coma
Prothrombin time 
(too slowly in 
seconds)
INR*
0-4 
<1.7
4-6 
1.7 – 2.3
>6 
>2.3
Note: *INR: International Normalized Ratio 
Table 1 – Classification of Child-Pugh score, in the groups 
with hepatitis B virus (HBV) and superinfected 
with hepatitis D virus (HBV+HDV), Cruzeiro do 
Sul, Acre, Brazil, 2007 to 2012
Classification Score
HBV HBV+HDV
n % n % n % p
A 5 21 95.5 22 59.5 43 72.9 0.12
6 1 4.5 7 18.9 8 13.6 0.15
B 7 0 0.0 3 8.1 3 5.1 0.18
8 0 0.0 2 5.4 2 3.4 0.28
9 0 0.0 3 8.1 3 5.1 0.18
Total --- 22 100.0 37 100.0 59 100.0 ---
Note: HBV – Hepatitis B virus; HDV – Hepatitis D virus.
Statistical analysis
The data was tabulated in a Microsoft Excel worksheet (Of-
fice 2010) and described by absolute and relative frequency. 
For statistical analysis of the categorical variables, the chi-
square test (x2) was used. Throughout statistical analysis, the 
5% significance level (α = 0.05) was adopted, that is, results 
with p <0.05 were considered to be statistically significant.
RESULTS
Of the 59 patients comprising the study population, 37.3% 
(n = 22) were in the HBV group and 62.7% (n = 37) in group 
HBV + HDV. The majority of subjects were male, represent-
ing 57.6% of the population. There was a similar distribution 
of this variable between the groups, since males represented 
55% and 59% of the medical records in groups HBV and HBV 
+ HDV, respectively.
According to the findings, only group HBV+HDV presented 
B scores (7-9), indicating a poor prognosis. Thus, when a com-
parison was made according to the distribution of scores A (indic-
ative of good prognosis) and B (indicative of poor prognosis), a 
significant difference was observed between the groups (Table 2).
Table 2 – Comparison of the Child-Pugh score classification 
A and B between the groups with hepatitis B vi-
rus (HBV) and superinfected with hepatitis D virus 
(HBV+HDV), Cruzeiro do Sul, Acre, Brazil, 2007 
to 2012
Classification
A
n (%)
B
n (%) p
Group HBV 22 (43.13%) 0 (-)
0.02
Group HBV+HDV 29 (56.86%) 8 (100.0)
Total 51 8
Note: Score A = 5-6 points; Score B = 7-9 points; HBV – Hepatitis B virus; HDV 
– Hepatitis D virus.
DISCUSSION
In the present study, 62.7% of the patients belonged to group 
HBV + HDV. With greater frequency, studies have reported a 
mean proportion of associated infection between 5% and 30% of 
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patients with HBV(7,23). In the Amazon region, presence of HDV 
antibodies (anti-HD) has already been estimated to be up to 34% 
of HBV carriers(24).
However, the estimates are not exact and often not even 
close when considering the peculiarities inherent to the vari-
ous communities in the region. An example of this is the re-
sult of a multicenter study of patients in outpatient care in the 
Western Amazon, which revealed a HDV infection rate rang-
ing from 47% to 65% of AgHB positive patients; values close 
to the results of this study(2).
However, it is necessary to emphasize that there have been 
few studies on the prevalence of HDV in Brazil(1). In addition, 
estimates of HDV infection are variable and may sometimes not 
correspond to the distribution of chronic HBV-infected patients(10).
Another aspect of the study concerns the sex and age of pa-
tients. HBV infection and HDV superinfection are often more 
endemic among males. An epidemiological study of molecular 
characterization carried out in the Brazilian Western Amazon 
presented a prevalence of 53.8% in men(24), a value similar to the 
56.7% observed in the population of the present study. When 
the age of the infected subjects was considered, two studies in 
the region also revealed a predominance of infection in young 
adults with mean age varying from 21.3(24) to 40(2) years.
Regarding the calculation and classification of the Child-
Pugh score, it was observed that the majority of patients, in 
both groups, presented classification A, indicative of a more 
favorable prognosis, when compared with classifications B 
and C. Patients with a score between 5 And 6, that is type A, 
present better survival rates(19).
When the groups were compared in relation to classifica-
tion A and B, the result showed a statistically significant differ-
ence (p = 0.02), and the HBV + HDV group was the only one 
to record classification B scores. The B score is related to com-
plications in hepatic function, such as cirrhosis and HCC(19), 
and is an indication of poor prognosis(18).
The observation that the prognostic estimate was worse among 
patients with HDV superinfection is in agreement with the re-
sults of studies available in the scientific literature that associate 
HDV superinfection with a greater severity of chronic liver disease 
characterized by accelerated evolution to the end-stages of the 
pathological process(12,21,25). It is noteworthy that these characteris-
tics have already been reported in the Brazilian Western Amazon(1).
In the geographical context, the Amazon region registers 
a high endemic pattern for HBV and HDV infections, charac-
terized by a series of difficulties in relation to diagnosis and 
control, due to its vast territorial dimension composed by mu-
nicipalities dispersed in the forest with difficult access, as well 
as the diverse ethnic composition of people affected(2).
Study Limitations and Contributions to the Nursing, Health, 
or Public Policy Area
This study has contributed to the advancement in knowl-
edge regarding the prognosis of patients with chronic hepa-
titis B and HDV superinfection, reaffirming the association 
between HDV superinfection and greater severity of liver dis-
ease. The use of prognostic estimation methods is useful for 
health care and nursing practice, as it allows nurses at any 
level of care to carry out individualized and consequently 
better quality care planning, due to the possibility of estimat-
ing future health conditions. Regarding the limitations of the 
study, it was performed in only one health care center.
CONCLUSION
The study showed that HDV superinfection, as already re-
ported in the scientific literature, was once again related to 
a poor prognosis, especially in the context of the Brazilian 
Western Amazon, where health technologies are scarce.
In addition, it is important to report that use of the Child-Pugh 
score as a mechanism to estimate the prognosis of patients with 
chronic hepatitis due to HBV and HDV superinfection, given its 
basic characteristics, requires multiple factors that range from the 
availability of technologies for the performance of the specific tests 
to a thorough clinical examination by a specialist—a condition 
that is scarce in many communities within the Western Amazon.
Finally, the use of the score allows an evaluation of the clinical 
conditions of patients with chronic liver disease due to HBV and 
superinfection with HDV. The prognosis obtained can be used as 
a parameter for therapeutic management of patients, prescription 
of priority care and indication for liver transplantation.
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